FDA Grants Emergency Use to Johnson & Johnson COVID-19 Vaccine

The Janssen/Johnson & Johnson SARS-CoV-2 vaccine becomes the third available to fight the pandemic in the US and the first designed for single-dose administration.
FDA Approvals

Source link